Hantz Financial Services’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9K | Buy |
126
+102
| +425% | +$7.29K | ﹤0.01% | 1546 |
|
|
2025
Q1 | $2K | Buy |
24
+16
| +200% | +$1.33K | ﹤0.01% | 1368 |
|
|
2024
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 1037 |
|
|
2024
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 1020 |
|
|
2024
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 1003 |
|
|
2024
Q1 | $1K | Sell |
8
-62
| -89% | -$7.75K | ﹤0.01% | 1123 |
|
|
2023
Q4 | $6K | Buy |
70
+61
| +678% | +$5.23K | ﹤0.01% | 881 |
|
|
2023
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 1072 |
|
|
2023
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 1036 |
|
|
2023
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 1058 |
|
|
2022
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 1019 |
|
|
2022
Q3 | $1K | Sell |
9
-2
| -18% | -$222 | ﹤0.01% | 1017 |
|
|
2022
Q2 | $1K | Sell |
11
-2
| -15% | -$182 | ﹤0.01% | 993 |
|
|
2022
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 989 |
|
|
2021
Q4 | $1K | Sell |
13
-6
| -32% | -$462 | ﹤0.01% | 838 |
|
|
2021
Q3 | $1K | Hold |
19
| – | – | ﹤0.01% | 790 |
|
|
2021
Q2 | $1K | Sell |
19
-585
| -97% | -$30.8K | ﹤0.01% | 782 |
|
|
2021
Q1 | $67K | Sell |
604
-990
| -62% | -$110K | ﹤0.01% | 513 |
|
|
2020
Q4 | $189K | Sell |
1,594
-634
| -28% | -$75.2K | 0.01% | 407 |
|
|
2020
Q3 | $194K | Buy |
+2,228
| New | +$194K | 0.01% | 379 |
|